Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA

Abstract

AbstractThe use of standardised reporting systems for non‐gynaecologic cytopathology has made enormous gains in popularity during the past decade, including for thyroid fine‐needle aspiration, urine cytology, serous effusions, pancreas, lymph nodes, lung and more. In February 2018, the first edition of the Atlas of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was published. The MSRSGC defines six diagnostic fine‐needle aspiration categories encompassing the spectrum of non‐neoplastic, benign and malignant lesions of the salivary glands. The goal of the MSRSGC is to combine each diagnostic category with a defined risk of malignancy and a specific clinical and/or surgical management algorithm. Since its initial publication in 2018, more than 200 studies and commentaries have been published, confirming the role of the MSRSGC. The second edition of the MSRSGC, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta‐analyses, a new chapter summarising the use of salivary gland imaging, new advances in ancillary testing and updates in nomenclature.